Teva Pharmaceutical Industries Limited Announces $3 Billion Share Repurchase Program

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $3 billion of its ordinary shares/ADRs from time to time, based on market conditions. At Teva’s current market capitalization, this amount would represent approximately 8 percent of the outstanding common stock.